Radiotherapy Aids Rectal Cancer Patients

Article

LONDON-A new study published in The Lancet reports rectal cancer patients who undergo radiotherapy have less of a risk of local recurring cancer. They are also less likely to die from rectal cancer than other patients who chose to not have radiation therapy.

The study, conducted by researchers at the University of Birmingham in the UK, examined 8507 patients with rectal cancer. They found that while the overall survival of those patients who underwent radiation therapy was only slightly higher, they did have a 46% less likely chance of recurring cancer than patients who opted for surgery alone.

Patients who chose to radiotherapy were also found to be less likely to die from their disease than patients who only had surgery to treat their cancer.

Information from www.givenimaging.com, Reuters Health

Recent Videos
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Meet Shannon Simmons, DHSc, MPH, CIC.
Clostridioides difficile  (Adobe Stock 260659307 by gaetan)
Weekly Rounds with Infection Control Today
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today's Trending Topic for March: Patient Safety
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Related Content